The improvement in each index in the high-dose experimental group was significantly better than that in the low-dose experimental group and the positive control group (<i>p</i> < 0.05).<h4>Conclusion</h4>Batri-7 can exert anti-inflammatory effects and treat salpingitis by regulating the TLR4/MyD8/NF-κB signalling pathway. Here, TLR4 is linked to salpingitis.